Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K

[Drug therapy of advanced pancreatic neuroendocrine tumor]

Raija Ristamäki, Maija Tarkkanen

    Duodecim; Laaketieteellinen Aikakauskirja
    |May 19, 2016
    PubMed

    Insights

    Limited randomized data exist for advanced pancreatic neuroendocrine tumors. Recent studies are complicated by patient crossover, small groups, and heterogeneity, hindering treatment application. Somatostatin analogues remain the primary supportive therapy.

    Area of Science:

    • Oncology
    • Endocrinology
    • Gastroenterology

    Context:

    • Advanced neuroendocrine cancer of pancreatic origin presents therapeutic challenges.
    • Existing drug therapies lack robust randomized study data.
    • Recent randomized trials are confounded by patient crossover and methodological limitations.

    Purpose:

    • To review current drug therapies for advanced pancreatic neuroendocrine cancer.
    • To highlight limitations in existing research data.
    • To discuss supportive care options.

    Summary:

    • Few randomized studies provide clear guidance for advanced pancreatic neuroendocrine tumors.
    • Methodological issues in recent trials obscure treatment effects.
    • Somatostatin analogue therapy is the main supportive option for hormonally active tumors.

    Impact:

    • Informs clinical decision-making for advanced pancreatic neuroendocrine cancer.
    • Identifies critical gaps in evidence for systemic therapies.
    • Emphasizes the role of somatostatin analogues in supportive care.

    More Related Videos

    Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models09:18

    Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

    Published on: February 3, 2026

    854

    Related Concept Videos

    Chronic Pancreatitis II: Collaborative Care01:29

    Chronic Pancreatitis II: Collaborative Care

    The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
    Assessment:
    466
    Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

    Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

    Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
    726
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    2.1K
    Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

    Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

    Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
    Phenothiazines, such as prochlorperazine...
    1.0K